Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond

P Rao, EE Knaus - Journal of pharmacy & …, 2008 - journals.library.ualberta.ca
Purpose. NSAIDs constitute an important class of drugs with therapeutic applications that
have spanned several centuries. Treatment of inflammatory conditions such as rheumatoid …

Mechanisms of resistance to photodynamic therapy

A Casas, G Di Venosa, T Hasan… - Current medicinal …, 2011 - ingentaconnect.com
Photodynamic therapy (PDT) involves the administration of a photosensitizer (PS) followed
by illumination with visible light, leading to generation of reactive oxygen species. The …

Clinical use and pharmacological properties of selective COX-2 inhibitors

S Shi, U Klotz - European journal of clinical pharmacology, 2008 - Springer
Abstract Selective COX-2 inhibitors (coxibs) are approved for the relief of acute pain and
symptoms of chronic inflammatory conditions such as osteoarthritis (OA) and rheumatoid …

Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages

MD Diaz-Munoz, IC Osma-Garcia, M Fresno… - Biochemical …, 2012 - portlandpress.com
PG (prostaglandin) E2 plays an important role in the modulation of the immune response
and the inflammatory process. In the present study, we describe a PGE2 positive feedback …

Eicosanoids in inflammation and cancer: the role of COX-2

S Agarwal, GV Reddy, P Reddanna - Expert review of clinical …, 2009 - Taylor & Francis
Eicosanoids, a family of oxygenated metabolites of eicosapolyenoic fatty acids, such as
arachidonic acid, formed via the lipoxygenase, cyclooxygenase (COX) and epoxygenase …

Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed

R Liu, KP Xu, GS Tan - European journal of pharmacology, 2015 - Elsevier
The most common and leading cause of cancer-related death in men is lung cancer. Despite
the recent advances in chemotherapy, advanced lung cancer still remains incurable. For …

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

S Tuyaerts, AMT Van Nuffel, E Naert, PA Van Dam… - BMC cancer, 2019 - Springer
Background Immunotherapeutic approaches have revolutionized oncological practice but
are less evaluated in gynecological malignancies. PD-1/PD-L1 blockade in gynecological …

COX-2 expression in malignant melanoma: a novel prognostic marker?

MR Becker, MD Siegelin, R Rompel, AH Enk… - Melanoma …, 2009 - journals.lww.com
Several studies illustrated considerably elevated levels of cyclooxygenase-2 (COX-2)
protein in various types of human cancer including malignant melanoma. Recently, it was …

Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells

QJ Chen, MZ Zhang, LX Wang - Cellular Physiology and Biochemistry, 2011 - karger.com
Abstract Aims: The ginsenoside Rg3 (Rg3) inhibits xenograft growth and angiogenesis in
tumors mainly via down-regulates VEGF expression. This study was designed to investigate …

Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression

S Serini, S Trombino, F Oliva, E Piccioni, G Monego… - Apoptosis, 2008 - Springer
Different agents able to modulate apoptosis have been shown to modify the expression of
the MAP-kinase-phosphatase-1 (MKP-1). The expression of this phosphatase has been …